Cargando…

Factors Impacting Pharmaceutical Prices and Affordability: Narrative Review

Increasing prescription drug pricing often reflects additional work stress on medical professionals because they function as financial advisors for patients and help them manage out-of-pocket expenses. Providers or prescribers wish to help patients with prescription costs but often lack related info...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Kah Seng, Kassab, Yaman Walid, Taha, Nur Akmar, Zainal, Zainol Akbar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838942/
https://www.ncbi.nlm.nih.gov/pubmed/33374493
http://dx.doi.org/10.3390/pharmacy9010001
_version_ 1783643296002736128
author Lee, Kah Seng
Kassab, Yaman Walid
Taha, Nur Akmar
Zainal, Zainol Akbar
author_facet Lee, Kah Seng
Kassab, Yaman Walid
Taha, Nur Akmar
Zainal, Zainol Akbar
author_sort Lee, Kah Seng
collection PubMed
description Increasing prescription drug pricing often reflects additional work stress on medical professionals because they function as financial advisors for patients and help them manage out-of-pocket expenses. Providers or prescribers wish to help patients with prescription costs but often lack related information. Healthcare plan providers try to display prescription and drug cost information on their websites, but such data may not be linked to electronic prescription software. A mark-up is defined as the additional charges and costs that are applied to the price of a product for the purpose of covering overhead costs, distribution charges, and profit. Therefore, the policies implemented in the pharmaceutical distribution chain might include the regulation of wholesale and retails mark-ups and pharmaceutical remuneration. If mark-ups are regulated, countries are highly recommended to use regressive mark-ups rather than fixed percentage mark-ups. This narrative review provides insights into the framework of pharmaceutical mark-up systems by describing different factors impacting pharmaceutical prices and affordability. These include the interplay of medicine pricing and the supply chain, the impact of pertinent laws and regulation and out-of-pocket expenditure.
format Online
Article
Text
id pubmed-7838942
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-78389422021-01-28 Factors Impacting Pharmaceutical Prices and Affordability: Narrative Review Lee, Kah Seng Kassab, Yaman Walid Taha, Nur Akmar Zainal, Zainol Akbar Pharmacy (Basel) Review Increasing prescription drug pricing often reflects additional work stress on medical professionals because they function as financial advisors for patients and help them manage out-of-pocket expenses. Providers or prescribers wish to help patients with prescription costs but often lack related information. Healthcare plan providers try to display prescription and drug cost information on their websites, but such data may not be linked to electronic prescription software. A mark-up is defined as the additional charges and costs that are applied to the price of a product for the purpose of covering overhead costs, distribution charges, and profit. Therefore, the policies implemented in the pharmaceutical distribution chain might include the regulation of wholesale and retails mark-ups and pharmaceutical remuneration. If mark-ups are regulated, countries are highly recommended to use regressive mark-ups rather than fixed percentage mark-ups. This narrative review provides insights into the framework of pharmaceutical mark-up systems by describing different factors impacting pharmaceutical prices and affordability. These include the interplay of medicine pricing and the supply chain, the impact of pertinent laws and regulation and out-of-pocket expenditure. MDPI 2020-12-23 /pmc/articles/PMC7838942/ /pubmed/33374493 http://dx.doi.org/10.3390/pharmacy9010001 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Lee, Kah Seng
Kassab, Yaman Walid
Taha, Nur Akmar
Zainal, Zainol Akbar
Factors Impacting Pharmaceutical Prices and Affordability: Narrative Review
title Factors Impacting Pharmaceutical Prices and Affordability: Narrative Review
title_full Factors Impacting Pharmaceutical Prices and Affordability: Narrative Review
title_fullStr Factors Impacting Pharmaceutical Prices and Affordability: Narrative Review
title_full_unstemmed Factors Impacting Pharmaceutical Prices and Affordability: Narrative Review
title_short Factors Impacting Pharmaceutical Prices and Affordability: Narrative Review
title_sort factors impacting pharmaceutical prices and affordability: narrative review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838942/
https://www.ncbi.nlm.nih.gov/pubmed/33374493
http://dx.doi.org/10.3390/pharmacy9010001
work_keys_str_mv AT leekahseng factorsimpactingpharmaceuticalpricesandaffordabilitynarrativereview
AT kassabyamanwalid factorsimpactingpharmaceuticalpricesandaffordabilitynarrativereview
AT tahanurakmar factorsimpactingpharmaceuticalpricesandaffordabilitynarrativereview
AT zainalzainolakbar factorsimpactingpharmaceuticalpricesandaffordabilitynarrativereview